Haemoglobin variability and all‐cause mortality in haemodialysis patients: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Haemoglobin variability and all‐cause mortality in haemodialysis patients: A systematic review and meta‐analysis

Published:2019-02-28 Issue:12 Volume:24 Page:1265-1272
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Zhao Lingfei¹²³⁴,Hu Chenxia⁵,Cheng Jun¹²³⁴,Zhang Ping¹²³⁴,Jiang Hua¹²³⁴,Chen Jianghua¹²³⁴^ORCID

Affiliation:

1. Kidney Disease Center, the First Affiliated Hospital, College of MedicineZhejiang University Hangzhou China

2. Key Laboratory of Kidney Disease Prevention and Control Technology Hangzhou China

3. National Key Clinical Department of Kidney DiseasesInstitute of Nephrology, Zhejiang University Hangzhou China

4. The Third Grade Laboratory under the National StateAdministration of Traditional Chinese Medicine Hangzhou China

5. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of MedicineZhejiang University Hangzhou China

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13560

Reference42 articles.

1. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

2. Association of Hemoglobin Variability and Mortality among Contemporary Incident Hemodialysis Patients

3. Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002

4. Evidence and implications of haemoglobin cycling in anaemia management

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Individualized Anemia Therapy on Hemoglobin Stability;Clinical Journal of the American Society of Nephrology;2024-06-11

2. Comparison of the hemoglobin variability in non-chronic kidney disease or end-stage renal disease participants and patients with CKD and ESRD;Clinical Nephrology;2024-04-01

3. The prevalence and risk factors of chronic kidney disease among type 2 diabetes mellitus follow-up patients at Debre Berhan Referral Hospital, Central Ethiopia;Journal of Clinical Nephrology;2023-02-16

4. Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies;Advances in Therapy;2023-02-07

5. Anemia biomarkers and mortality in hemodialysis patients with or without diabetes: A 10-year follow-up study;PLOS ONE;2023-01-31